Featured
Read our handpicked blogs, curated for you.
|
The Rising Risk in Modern Digital WorkplacesEmployees share files across Teams, SharePoint, email, and external…
|
The AI Governance Challenge in 2026Copilot and autonomous AI agents are rolling out rapidly across enterprises. They…
|
The Control Crisis in Digital WorkplacesShadow IT, permission sprawl, and configuration drift create growing risks.…
Recent releases
|
Tier 2 and Tier 3 Doctors The Untapped Goldmine of Indian Pharma Marketing
For decades, Indian pharma marketing has revolved around Tier 1 cities. Mumbai, Delhi, Bangalore, Chennai- this is where companies concentrated their field force, budgets, and campaigns. But here’s…
|
Tier 2 and Tier 3 Doctors: Pharma’s Untapped Growth Engine
For years, Indian pharma marketing has been obsessed with metros. Strategies are designed for doctors in Mumbai, Delhi, Bangalore, and Hyderabad, as if prescribing behavior outside these hubs hardly…
|
Cutting Pharma Content Approval Cycles with Modular Ops
Every pharma marketer in India knows the feeling. A new campaign is planned, deadlines are set, and the brand team is ready to move. Then the medical-legal-regulatory (MLR) process begins. Weeks go…
|
The UCPMP 2024 Rulebook- What Pharma CMOs Need to Change in Marketing Ops
For years, Indian pharma operated in a grey zone where marketing practices were loosely monitored. That time is over. The UCPMP 2024 Rulebook (Uniform Code of Pharmaceutical Marketing Practices) has…
